Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway

被引：4

作者：

Chen, Yao-Xin ^{[1
]}

Deng, Zhi-Hua ^{[1
]}

Xue-Gao, Guang-Hua ^{[1
]}

Qiang-Du, Jun-Gen ^{[1
]}

Juan-Yin, Yi-Ming ^{[2
]}

Chen, Guang-Hua ^{[3
]}

Li, Jun-Gen ^{[4
]}

Zhao, Yi-Ming ^{[3
]}

Zhang, Hao-Tian ^{[5
]}

Zhang, Guo-Xing ^{[5
,6
]}

Qian, Jin-Xian ^{[1
,7
]}

机构：

[1] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou Municipal Hosp, Gusu Sch,Dept Resp & Crit Care Med, Suzhou, Peoples R China

[2] Suzhou Municipal Hosp, Dept Cent Lab, Suzhou, Peoples R China

[3] Suzhou Univ, Affiliated Hosp 1, Natl Clin Med Res Ctr Hematol, Jiangsu Hematol Inst,Dept Hematol, Suzhou, Peoples R China

[4] Suzhou Univ, Affiliated Hosp 1, Dept Emergency Med, Suzhou, Peoples R China

[5] Soochow Univ, Med Coll, Dept Physiol & Neurosci, Suzhou, Peoples R China

[6] Soochow Univ, Med Coll, Dept Physiol & Neurosci, 199 Ren Ai Rd,Dushu Lake Campus,Suzhou Ind Pk, Suzhou 215123, Peoples R China

[7] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou Municipal Hosp, Gusu Sch,Dept Resp & Crit Care Med, Guanji Rd 242, Suzhou 215008, Peoples R China

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2023年 / 168卷

关键词：

Hypoxic pulmonary hypertension (HPH); Mesenchymal Stem Cell (MSC); Exosome; Proliferation; YAP1/SPP1 signaling pathway; Pulmonary artery smooth muscle cell (PASMC); PROLIFERATION;

D O I：

10.1016/j.biopha.2023.115816

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Objective: Hypoxic pulmonary hypertension (HPH) is a progressive and life-threatening disease characterized by perivascular inflammation, pulmonary vascular remodeling, and occlusion. Mesenchymal stromal cell-derived exosomes (MSC-exo) have emerged as potential therapeutic agents due to their role in cell communication and the transportation of bioactive molecules. In this study, we aimed to investigate the therapeutic effects of MSC-exo against HPH and elucidate the underlying molecular mechanism. Methods: Exosomes were isolated from conditioned media of human bone mesenchymal stromal cells using ultracentrifugation and characterized through western blotting, transmission electron microscopy (TEM), and nanoparticle tracking analysis (NTA). An HPH animal model was established in male SD rats, and MSC-exo or phosphate-buffered saline (PBS) were administered via the tail vein for three weeks. Subsequently, right ventricular systolic pressure (RVSP), right ventricular hypertrophy index (RVHI), and pulmonary vascular remodeling were evaluated. Lung tissues from HPH rats and normal rats underwent high-throughput sequencing and transcriptomic analysis. Gene Ontology (GO) analysis was employed to identify upregulated differentially expressed genes. Additionally, rat pulmonary artery smooth muscle cells (PASMC) exposed to platelet-derived growth factor-BB (PDGF-BB) were used to simulate HPH-related pathological behavior. In vitro cellular models were established to examine the molecular mechanism of MSC-exo in HPH. Results: MSC-exo administration protected rats from hypoxia-induced increases in RVSP, RVHI, and pulmonary vascular remodeling. Additionally, MSC-exo alleviated PDGF-BB-induced proliferation and migration of PASMC. Transcriptomic analysis revealed 267 upregulated genes in lung tissues of HPH rats compared to control rats. Gene Ontology analysis indicated significant differences in pathways associated with Yes Associated Protein 1 (YAP1), a key regulator of cell proliferation and organ size. RT-qPCR and western blot analysis confirmed significantly increased expression of YAP1 in HPH lung tissues and PASMC, which was inhibited by MSC-exo treatment. Furthermore, analysis of datasets demonstrated that Secreted Phosphoprotein 1 (SPP1), also known as Osteopontin (OPN), is a downstream binding protein of YAP1 and can be upregulated by PDGF-BB. MSC-exo treatment reduced the expression of both YAP1 and SPP1. Lentivirus-mediated knockdown of YAP1 inhibited PDGF-BB-induced PASMC proliferation, migration, and SPP1 protein levels. Conclusion: Our findings demonstrate that MSC-exo exert a therapeutic effect against hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway. The inhibition of YAP1 and downstream SPP1

引用

页数：14